Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 152 participants.

Also called NCT02475642

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 152 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02475642
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02475642. Randomized; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation
Acronym
POWDER-AF
Intervention (Other)
PVI-ADT
Intervention (Other)
PVI+ADT
Lead sponsor
VZW Cardiovascular Research Center Aalst (class: other)
Collaborator
AZ Sint-Jan AV (class: other)

Record details

Record id
cardio:ct-nct02475642
Content hash
b353e0130e8926eb059f03a116e6c8b7f4cd4348a8d00b210a1c716197c3a511